HRP980097B1 - Combinatory compositions for the treatment of dementia - Google Patents
Combinatory compositions for the treatment of dementiaInfo
- Publication number
- HRP980097B1 HRP980097B1 HR980097A HRP980097A HRP980097B1 HR P980097 B1 HRP980097 B1 HR P980097B1 HR 980097 A HR980097 A HR 980097A HR P980097 A HRP980097 A HR P980097A HR P980097 B1 HRP980097 B1 HR P980097B1
- Authority
- HR
- Croatia
- Prior art keywords
- carbon atoms
- branched
- straight
- carbon chain
- alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19707655A DE19707655A1 (de) | 1997-02-26 | 1997-02-26 | Kombinationspräparat zur Anwendung bei Demenz |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP980097A2 HRP980097A2 (en) | 1998-12-31 |
HRP980097B1 true HRP980097B1 (en) | 2006-09-30 |
Family
ID=7821517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR980097A HRP980097B1 (en) | 1997-02-26 | 1998-02-25 | Combinatory compositions for the treatment of dementia |
Country Status (30)
Country | Link |
---|---|
US (1) | US6037347A (xx) |
EP (1) | EP0867192B1 (xx) |
JP (1) | JP4374440B2 (xx) |
KR (1) | KR100517186B1 (xx) |
CN (1) | CN100363005C (xx) |
AR (1) | AR011860A1 (xx) |
AT (1) | ATE295738T1 (xx) |
AU (1) | AU749278C (xx) |
BR (1) | BR9800766A (xx) |
CA (1) | CA2230350C (xx) |
CZ (1) | CZ298367B6 (xx) |
DE (2) | DE19707655A1 (xx) |
DK (1) | DK0867192T3 (xx) |
EE (1) | EE03387B1 (xx) |
ES (1) | ES2242243T3 (xx) |
HR (1) | HRP980097B1 (xx) |
HU (1) | HUP9800396A3 (xx) |
ID (1) | ID19941A (xx) |
IL (1) | IL123453A (xx) |
MY (1) | MY120530A (xx) |
NO (1) | NO327200B1 (xx) |
NZ (1) | NZ329839A (xx) |
PL (1) | PL191576B1 (xx) |
PT (1) | PT867192E (xx) |
RU (1) | RU2194508C2 (xx) |
SI (1) | SI0867192T1 (xx) |
SK (1) | SK284925B6 (xx) |
TR (1) | TR199800302A2 (xx) |
TW (1) | TW590772B (xx) |
ZA (1) | ZA981561B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2237163T3 (es) * | 1998-10-01 | 2005-07-16 | Novartis Ag | Nuevas formulaciones orales de revastigmina de liberacion controlada. |
US20040110776A1 (en) * | 2002-02-22 | 2004-06-10 | Iok-Hou Pang | Use of propentofylline to control intraocular pressure |
WO2004028634A1 (en) * | 2002-09-25 | 2004-04-08 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating alzheimer's disease and dementias of vascular origin |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
MX2007007836A (es) | 2004-12-27 | 2007-08-20 | Eisai R&D Man Co Ltd | Metodo para estabilizar un farmaco anti-demencia. |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
WO2006118265A1 (ja) * | 2005-04-28 | 2006-11-09 | Eisai R & D Management Co., Ltd. | 抗痴呆薬を含有する組成物 |
EP4019018A1 (en) | 2015-09-11 | 2022-06-29 | Chase Pharmaceuticals Corporation | Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system |
RU2616247C1 (ru) * | 2016-03-28 | 2017-04-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) | Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3737433A (en) * | 1964-09-05 | 1973-06-05 | Albert Ag Chem Werke | Certain oxoalkyldimethylxanthines |
US3621096A (en) * | 1969-04-03 | 1971-11-16 | Univ North Carolina | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone |
DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
DE2856393C2 (de) * | 1978-12-27 | 1983-04-28 | Merz + Co GmbH & Co, 6000 Frankfurt | Arzneimittel zur Behandlung von Morbus Parkinson |
JPH062675B2 (ja) * | 1985-04-05 | 1994-01-12 | ヘキストジヤパン株式会社 | 記憶障害治療剤 |
DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
IL81610A (en) * | 1986-02-27 | 1990-12-23 | Roussel Uclaf | Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them |
GB8621870D0 (en) * | 1986-09-11 | 1986-10-15 | Beecham Group Plc | Active compounds |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
IL87861A0 (en) * | 1987-10-05 | 1989-03-31 | Pfizer | 4-aminopyridine derivatives |
WO1989002739A1 (en) * | 1987-10-05 | 1989-04-06 | Pfizer Inc. | 4-aminopyridine derivatives |
DE3817955A1 (de) * | 1988-05-27 | 1989-11-30 | Hoechst Ag | Tnf-inhibitor enthaltendes arzneimittel |
JPH05506842A (ja) * | 1989-09-15 | 1993-10-07 | ジェンシア・ファーマシュウティカルズ・インコーポレイテッド | 神経変性状態の処置方法 |
DE4236331A1 (de) * | 1992-10-28 | 1994-05-05 | Boehringer Ingelheim Kg | Synergistische Kombination |
US5783584A (en) * | 1995-12-11 | 1998-07-21 | Mayo Foundation For Medical Education And Research | THA analogs useful as cholinesterase inhibitors |
GB9612710D0 (en) * | 1996-06-18 | 1996-08-21 | Pfizer Ltd | Method of treatment |
-
1997
- 1997-02-26 DE DE19707655A patent/DE19707655A1/de not_active Withdrawn
-
1998
- 1998-02-16 ES ES98102620T patent/ES2242243T3/es not_active Expired - Lifetime
- 1998-02-16 DE DE59812801T patent/DE59812801D1/de not_active Expired - Lifetime
- 1998-02-16 PT PT98102620T patent/PT867192E/pt unknown
- 1998-02-16 ID IDP980209A patent/ID19941A/id unknown
- 1998-02-16 EP EP98102620A patent/EP0867192B1/de not_active Expired - Lifetime
- 1998-02-16 DK DK98102620T patent/DK0867192T3/da active
- 1998-02-16 AT AT98102620T patent/ATE295738T1/de not_active IP Right Cessation
- 1998-02-16 SI SI9830775T patent/SI0867192T1/xx unknown
- 1998-02-23 EE EE9800075A patent/EE03387B1/xx not_active IP Right Cessation
- 1998-02-24 SK SK240-98A patent/SK284925B6/sk not_active IP Right Cessation
- 1998-02-24 TW TW087102577A patent/TW590772B/zh not_active IP Right Cessation
- 1998-02-24 AU AU56273/98A patent/AU749278C/en not_active Ceased
- 1998-02-24 TR TR1998/00302A patent/TR199800302A2/xx unknown
- 1998-02-24 CA CA002230350A patent/CA2230350C/en not_active Expired - Fee Related
- 1998-02-24 RU RU98103712/14A patent/RU2194508C2/ru not_active IP Right Cessation
- 1998-02-24 NZ NZ329839A patent/NZ329839A/xx unknown
- 1998-02-24 CZ CZ0054098A patent/CZ298367B6/cs not_active IP Right Cessation
- 1998-02-24 AR ARP980100810A patent/AR011860A1/es not_active Application Discontinuation
- 1998-02-25 MY MYPI98000834A patent/MY120530A/en unknown
- 1998-02-25 HU HU9800396A patent/HUP9800396A3/hu unknown
- 1998-02-25 BR BR9800766-1A patent/BR9800766A/pt not_active Application Discontinuation
- 1998-02-25 ZA ZA981561A patent/ZA981561B/xx unknown
- 1998-02-25 IL IL12345398A patent/IL123453A/en not_active IP Right Cessation
- 1998-02-25 CN CNB981053289A patent/CN100363005C/zh not_active Expired - Fee Related
- 1998-02-25 US US09/030,207 patent/US6037347A/en not_active Expired - Lifetime
- 1998-02-25 HR HR980097A patent/HRP980097B1/xx not_active IP Right Cessation
- 1998-02-25 NO NO19980786A patent/NO327200B1/no not_active IP Right Cessation
- 1998-02-25 JP JP04305898A patent/JP4374440B2/ja not_active Expired - Fee Related
- 1998-02-26 KR KR10-1998-0006051A patent/KR100517186B1/ko not_active IP Right Cessation
- 1998-02-26 PL PL325074A patent/PL191576B1/pl not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9305930A (es) | Derivados de piperidina, su preparacion y su aplicacion en terapeutica. | |
HRP980097B1 (en) | Combinatory compositions for the treatment of dementia | |
BG102945A (en) | Carbamide derivatives as inhibitors of enzyme inosine-5'-monophosphate dehydrogenase | |
DE69425431T2 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
DK0828728T3 (da) | Phenyldihydrobenzofuraner | |
DE60137966D1 (de) | Anilinopyrimidin derivate als "jnk pathway inhibitoren", zusammensetzungen und damit verbundene behandlungsmethoden | |
BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
HUP0001122A2 (hu) | Farnezil-transzferáz-gátló kinazolinonok | |
BR0312685A (pt) | Métodos de utilização de compostos do tipo artemisinina para prevenir ou retardar o aparecimento de cancêr | |
AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
HUP0400314A2 (hu) | Gyógyszer-kombinációk rák kezelésére | |
ATE228507T1 (de) | Substituierte 6-phenylphenanthridine | |
FI951454A0 (fi) | 1-(2-oksoasetyyli)piperidiini-2-karboksyylihappojohdannaiset monille lääkkeille resistenttien syöpäsolujen herkistäjinä | |
TR200000022T2 (tr) | 3-ya da 4-eşlenimli 4-(aminometil)-piperidin türevlerinin tek halkalı gastrokinetik benzamidleri. | |
ATE239012T1 (de) | Triazin angiogenese-inhibitoren | |
BR9811093A (pt) | Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo) | |
ATE230404T1 (de) | Cyclohexyldihydrobenzofurane | |
TR200103624T2 (tr) | Amof bileşikler ve bunların farmasötik bileşimleri. | |
BR9604907B1 (pt) | derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral com princìpios ativos. | |
MY159418A (en) | New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use | |
DE69609382D1 (de) | Amidin-Derivate und Blutplättchen-Aggregationsinhibitoren, die sie enthalten | |
ATE209172T1 (de) | 1,3-diphenylpropanderivate mit hemmender aktivität gegen tyrosinase und verfahren zu deren herstellung | |
CO4940439A1 (es) | COMPUESTOS 4-AMINO-6,7-DISUSTITUIDOS-PIRIDO-[2,3-d] PIRIMI- DINA | |
IL117497A0 (en) | 17-Difluoromethylene estratriene derivatives and pharmaceutical compositions containing the same | |
TH118855A (th) | อนุพันธ์ของ 4-อะมิโน-5-ไซยาโนพิริมิดีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090223 Year of fee payment: 12 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20100226 |